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I. Abstract 
Sepsis and septic shock continue to be major causes of in-hospital mortality.1  The World Health 
Organization (WHO) declared sepsis as a global health top priority as of 2017.1  To combat 
sepsis mortality, the Surviving Sepsis Campaign (SSC) released the first set of guidelines in 
2004 and continues to publish treatment guidelines, updating the guidelines every four years 
based on emerging evidence.2  The 2018 update to the 2016 guidelines contains an Hour-1 
Bundle released by the SSC, which includes a rapid infusion of a 30 ml/kg fluid bolus as a strong 
recommendation with low quality evidence.3  Recently, studies have challenged this 
recommendation, demonstrating complications due to fluid overload when following the 
guideline.4,5  This continues to be a source of controversy, as the fluid bolus is included in the 
Centers for Medicare and Medicaid Services SEP-1 performance measure, requiring healthcare 
practitioners to administer the bolus despite the risks of harm.5  A literature review was 
conducted utilizing PubMed to explore the following question: in adult patients with sepsis or 
septic shock, does initially administering at least 30 ml/kg of fluid improve morbidity and 
mortality compared to other treatment modalities, such as a fluid restrictive approach or early 
introduction of vasopressors?  The null hypothesis was that there would be no difference 
amongst treatment modalities.  This review revealed that giving a standard 30 ml/kg fluid bolus 
may be harmful, potentially leading to poorer outcomes.  Alternative fluid administration 
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II. Introduction 
 Throughout history, sepsis has been a challenge to patients and healthcare providers 
alike.  The term sepsis  dates back as far as the times of Hippocrates, who considered sepsis to 
be the process of faster rotting flesh and wounds.1  In more recent times, sepsis has been 
considered one of the top global health priorities by the World Health Organization.1 Sepsis 
affects over 750,000 patients a year, over 210,000 of which will die as a result.6  Roughly 15% of 
patients with sepsis progress into septic shock, accounting for 10% of intensive care unit (ICU) 
admissions and carries a 35% to 50% mortality rate. 6,7  One study estimated the mortality of 
patients in septic shock to be as high as 40% to 80%.8  As one can imagine, the cost of care and 
mortality is directly proportional to the severity of the patient s sepsis.8  Not only is sepsis a 
condition of high mortality but also associated with high costs.  The healthcare cost associated 
with sepsis in the United States is more than $20.3 billion annually and rising.7  From 2012 to 
2018 alone, the cost of caring for septic patients more than doubled, rising from $6.0 billion to 
$13.4 billion annually.9  
As knowledge of sepsis pathophysiology increases, the definition has evolved. In 1991, 
the systemic inflammatory response syndrome (SIRS) criteria was introduced.7  In 2015, the 
Centers for Medicare and Medicaid Services (CMS) instituted an all-or-none sepsis bundle (SEP-
1) to promote high quality and cost effective care of sepsis patients.10  In 2016, the International 
Consensus Sepsis-3 issued updated definitions for both sepsis and septic shock.11  Sepsis is 
defined as life-threatening dysfunction resulting from dysregulated host response to an 
infection.11  Septic shock is then defined as a subset of sepsis with the characteristics of profound 
circulatory, cellular, and metabolic abnormalities.7  Clinically, high risk sepsis can be identified 
using the SIRS criteria or a qSOFA score of two or more points, while septic shock can be 
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identified using a mean arterial pressure (MAP) of 65 mmHg or greater and a serum lactate of 2 
mmol/L or greater in the absence of hypovolemia.7   
To help combat sepsis in patients, the Surviving Sepsis Campaign (SSC) was launched in 
2002 with the Barcelona Declaration.2  This collaborative mission amongst the European Society 
of Intensive Care Medicine (ESICM), the International Sepsis Forum (ISF), and the Society of 
Critical Care Medicine (SCCM) aimed to reduce the mortality of sepsis by 25% through the 
development of evidence-based guidelines.2  The 2018 update to the 2016 SSC guidelines 
introduced the Hour-1 Bundle consisting of measuring serum lactate levels, obtaining blood 
cultures, rapidly infusing 30 ml/kg crystalloid for hypotension or lactate levels of 4 mmol/L or 
greater, and administering vasopressors if the patient is hypotensive during or after fluid 
resuscitation with a MAP goal of 65 mmHg or greater.3 
As more research has been conducted analyzing the outcomes of septic patients, the rapid 
administration of at least 30 ml/kg crystalloid fluid bolus given within the first three hours has 
been questioned.5  This came as a strong recommendation with low quality evidence from the 
SSC 2016 guidelines.12  Recent studies have shown that this bolus commonly results in fluid 
overload and a harmful sequelae, leading to increased interventions and greater mortality.5,13  In 
some states, such as New York, practitioners are required by the SEP-1 mandate to administer 
the 30 ml/kg fluid bolus to septic patients or face a malpractice lawsuit, despite the risk of further 
harm to the patient.5  In cases of patients with pneumonia or acute lung injury who are septic, 
this means the patients are intubated and placed on a mechanical ventilator, so they can receive 
the potentially harmful fluid bolus.14  This potentially goes against the ethical principles of 
nonmaleficence that is carried by medical providers.   
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It is within the realm of conflicting guidelines and disagreements that the focus of this 
paper arises.  The research paper is intended to review current medical literature to answer the 
following question: in adult patients with sepsis or septic shock, does initially administering at 
least 30 ml/kg of fluid improve morbidity and mortality compared to other treatment modalities, 
such as a fluid restrictive approach or early introduction of vasopressors?  The null hypothesis of 
this review is that there is no significant difference in morbidity and mortality despite the 
different treatment modalities.  The objectives of this paper include a brief overview of the 
pathophysiology of sepsis; an overview of current Surviving Sepsis Campaign recommendations, 
origins, and critiques; a review of fluid management principles of sepsis and septic shock; a 
review of post-fluid administration physiology; and an overview of fluid resuscitation 
approaches, complications, and outcomes in sepsis and septic shock. 
III. Literature Review 
Brief Pathophysiology of Sepsis 
 The pathophysiology of sepsis in patients involves a complex cascade of multisystem 
organ dysfunction as a result of systemic infection.15  As the pathophysiology of sepsis has been 
described in detail elsewhere, a brief overview is provided for this paper.15-16  While some 
patients mount a proper immune response to an antigen and will clear the infection without 
further complications or deterioration, others enter into a dysregulated state of the immune 
response.15  This can progress into patient deterioration leading to septic shock and eventually 
death without prompt intervention.15  Previously, a cytokine storm  of inflammatory mediators 
was thought to be the cause of this dysregulation.15  However, recent studies suggest that both 
proinflammatory as well as anti-inflammatory mediators are released in a septic state, each 
playing a role in the dysfunction.15  An excess of proinflammatory mediators released in the 
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bloodstream can cause systemic damage to the endothelial tissue of the vasculature.15  This can 
lead to hyperpermeability of blood vessels secondary to the loss of barrier function of the 
endothelial lining.16  Multi-system organ failure can develop as a result and can lead to death.15  
Almost every body system is ultimately affected, including the cardiovascular, pulmonary, renal, 
hematological, gastrointestinal, endocrine, and neurological systems.5,15 
In the cardiovascular system, pathologic arterial and venodilation can lead to potentially 
life-threatening hypotension, as seen in septic shock.15  Hypotension in septic patients results 
from decreased venous return (decreased preload), loss of intravascular volume due to third 
spacing of intravascular fluid (tissue edema), and myocardial depression, which is seen in up to 
60% of septic patients.15  The cause is multifactorial involving inflammatory cytokines, nitrous 
oxide released by damaged endothelial tissue, and hyperpermeability of the vasculature.5,15,16 In 
addition to a low MAP, patients in early stages of septic shock can either exhibit a high cardiac 
output state (hyperdynamic circulatory shock) or low cardiac output state (sepsis with severe 
hypovolemia or sepsis-induced cardiomyopathy).17  One important component of the vascular 
dysfunction seen in septic patients is the endothelial glycocalyx.16  Normally acting as an 
endothelial gatekeeper,  early shedding of this important layer in sepsis causes disruption of the 
endothelial tissue, resulting in damage to the endothelial cells and ultimately dysfunction.18  The 
loss of the barrier function normally provided by the endothelial glycocalyx is a key component 
contributing organ dysfunction seen in sepsis.16 
In the pulmonary system, increased permeability of the alveolar and capillary 
endothelium results in the accumulation of fluid in the lungs.15  This noncardiogenic pulmonary 
edema can ultimately progress into acute respiratory distress syndrome (ARDS) in up to 7% of 
patients with sepsis.15  The accumulation of fluid in the patient s lungs impairs their ability to 
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oxygenate and ventilate properly, resulting in hypoxia and further potentiating metabolic 
acidosis.15 
In the renal system, acute kidney injury (AKI) may occur in patients with sepsis, 
contributing to morbidity and mortality.15  Subsets of patients, such as those who are of advanced 
age or have underlying chronic kidney disease and/or cardiovascular disease, are at higher risk 
for developing AKI with sepsis.15  Multiple factors contribute to the development of AKI in 
sepsis patients, including endothelial dysfunction, inflammation of the renal parenchyma, and 
obstruction of the renal tubules from debris as a result of apoptosis.15  Initial prevention of AKI 
in sepsis patients is essential, and the risk can be minimized with prompt correction of 
hypotension and avoiding other potentiating factors, such as unnecessary nephrotoxic 
medications.15 
In addition to those listed above, other body systems are affected in sepsis.  
Hematologically, sepsis can cause anemia, leukocytosis, neutropenia, thrombocytopenia, and in 
severe cases, disseminated intravascular coagulation (DIC).15  In the gastrointestinal system, 
liver failure can develop secondary to septic shock, increasing the mortality risk for the patient.15  
Occurring in less than 2% of patients with sepsis, liver failure is thought to arise from 
parenchymal hypoxia.15  Other manifestations include cholestasis, coagulopathies, and 
hyperammonemia leading to hepatic encephalopathy.15  Hyperglycemia is commonly seen in 
patients with sepsis, caused by elevation in glucagon, catecholamines, cortisol, and other factors 
as part of the stress response.15  Clinical hypothyroidism may also be seen as the result of 
impairment of the hypothalamic-pituitary-thyroid axis.15  Lastly, sepsis can have profound 
impacts on the neurological system as a result of systemic dysfunction, spanning from altered 
mental status, sleep disturbance, agitation and hallucinations to seizures, which occur secondary 
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to encephalopathy and more. 15  Due to the wide variety of systemic pathology, it is important for 
clinicians to rapidly recognize a septic patient and initiate prompt treatment to minimize the 
sequelae caused by sepsis. 
Surviving Sepsis Campaign Recommendations 
 In 2016, the Surviving Sepsis Campaign (SSC) released its most recent recommendations 
with a subsequent update in 2018.3,12  Although there are many recommendations regarding 
treatment and care, the focus for this paper will remain on the resuscitation aspect of septic 
patients, involving fluid resuscitation and the use of vasopressors.   One of the most notable 
changes in the 2018 update is the replacement of the three and six hour treatment bundles with a 
single Hour-1 Bundle.3  This was made to promote rapid resuscitation and management in these 
patients.10  Time zero  is a term synonymous with time of presentation and is used to describe 
the timeframe from which interventions should be performed.3  The Surviving Sepsis 
Campaign s focus on rapid diagnosis and immediate action in treating septic patients was the 
result of studies which showed an association between increased bundle compliance and 
decreased mortality in septic patients.3   
 The focus of the Hour-1 Bundle remains on obtaining initial lactate levels and blood 
cultures, administering broad-spectrum antibiotics, beginning a rapid infusion of 30 ml/kg 
crystalloid for hypotension or lactate ≥ 4 mmol/L, and administering vasopressors if the patient 
is hypotensive during or after fluid administration with a goal MAP of ≥ 65 mmHg.3  Studies 
have demonstrated improved outcomes, such as mortality, with proper adherence to the SSC 
bundles; however, the specific benefit of each component in the bundle remains less clear.19   
According to the SSC 2018 update, the rapid infusion of 30 ml/kg of crystalloid should 
be completed in the first three hours of care.3  The evidence for the rapid administration of 30 
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ml/kg of crystalloid is of low quality, yet carries a strong recommendation.3  The 2018 update 
also stressed that due to evidence suggesting harm with a sustained positive fluid balance in 
septic patients, caution should be used when administering additional fluids beyond the initial 
rapid infusion of cyrstalloid.3  In regards to vasopressors, the recommendations are to initiate a 
vasopressor if the patient remains hypotensive during the first hour of the fluid resuscitation to 
maintain a MAP ≥ 65 mmHg.3  Based on studies examining the benefits of individual 
vasopressors, norepinephrine is recommended as a first-line vasopressor.3  If the patient remains 
hypotensive despite fluid and norepinephrine infusions, other vasopressors such as epinephrine 
and vasopressin may be considered.3 
Origins of the Surviving Sepsis Campaign Recommendations  
Before analyzing the outcomes of the recommended 30 ml/kg bolus of intravenous fluids, 
it is important to understand where this SSC recommendation originated.  In 2001, Rivers et al. 
conducted a single-center randomized controlled trial (RCT) evaluating the efficacy of early 
goal-directed therapy (EGDT) versus standard therapy in septic patients prior to admission into 
the ICU.19  In this study, the authors concluded that there was a significant benefit in patient 
outcome by using aggressive fluid resuscitation to achieve macrocirculation goals of central 
venous pressure (CVP) of 8 mmHg or greater and MAP of 65 mmHg or greater and 
microcirculation goals of a central venous oxygen saturation (SvO2) at 70% or greater.19  The 
aggressive fluid resuscitation approach resulted in a reduction of mortality from 46.5% to 
30.5%.19  The subsequent endorsement of this study by the SSC started a new era of aggressive 
fluid resuscitation in sepsis patients.5   
Following this study, the Trial of Early Goal-Directed Resuscitation Septic Shock 
(ProMISe), Protocol-based Care for Early Septic Shock (ProCESS), and Goal-Directed 
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Resuscitation for Patients with Early Septic Shock (ARISE) trials were conducted to evaluate the 
efficacy of the EGDT endorsed by the SSC.20-22  All three of these trials showed no significant 
reduction in mortality while following the EGDT protocol.20-22  In support of the guidelines of 
EGDT, the International Multicenter Prevalence Study on Sepsis (IMPreSS) study showed a 
reduction in mortality by 40% when in compliance with the guidelines.5 In addition, Levy et al. 
showed that increased compliance with the guidelines resulted in a reduction in mortality in 
septic patients.5  It is important to note, however, that these studies were uncontrolled 
longitudinal observational studies, which inherently weakens the conclusions drawn.  
Furthermore, they did not assess the effect of fluid administration independently but rather as 
part of the overall sepsis treatment bundle.5 Another large study that focused on independently 
assessing variables, including the time of fluid bolus administration, found there was no change 
in mortality with faster fluid administration (3 hours compared to 12 hours).23  An additional 
study demonstrated patients who received more than five liters of fluid during the first day in the 
hospital had a significantly increased risk of death.5  These conflicting results call into question 
the efficacy of administering a rapid 30 ml/kg crystalloid bolus to patients with sepsis. 
Critiques of the Surviving Sepsis Campaign Recommendations 
Conflicting results from studies evaluating the SSC guidelines for administering a rapid 
fluid bolus of crystalloid point out the inherent vagueness to it.  There is no mention within the 
guideline of whether the patient s actual weight, predicted weight, or ideal body weight should 
be used in the calculation.3,12  This could potentially result in fluid overload for patients with 
obesity or, conversely, under-resuscitation of patients who are extremely underweight.  
Considering the guideline has a fixed volume of 30 ml/kg, this all-or-nothing approach can 
potentially cause harm associated with fluid overload.5  One study found that the SSC guidelines 
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led to evidence of fluid overload in 67% of patients, of which 48% of patients still had fluid 
overload on day three.13  This resulted in increased medical interventions, such as thoracentesis, 
paracentesis, diuretic use, and ultrafiltration, in addition to increased hospital mortality.13  Due to 
the lack of scientific evidence and potential harm to patients, blindly administering at least 30 
ml/kg of crystalloid fluid within the first three hours, as required by the CMS in their 
performance measures in the SEP-1 mandate, has been questioned.10 
Fluid Management Principles of Sepsis and Septic Shock 
 The main goal of fluid resuscitation in sepsis and septic shock is to replenish the lost 
intravascular volume, improve tissue perfusion and oxygenation, and reverse organ dysfunction.7  
Per the Surviving Sepsis Campaign recommendations, this should be completed by an infusion 
of 30 ml/kg crystalloid over three hours.3,12  Conceptually, increasing the intravascular volume 
will increase preload and translate into a higher cardiac output and a higher MAP.7  Studies 
suggest that a MAP ≥ 65 mmHg is necessary to maintain proper organ perfusion and maximize 
survival.12 
Within medical literature, the terms fluid bolus, challenge, balance, and overload are 
commonly used.  Fundamentally, a fluid bolus and a fluid challenge can be used synonymously.  
Fluid bolus itself refers to a discrete amount of fluid given to a patient over a specified amount of 
time.17  A fluid challenge refers to a dynamic test in which a fluid bolus is administered and 
physiologic effects are simultaneously monitored.17  Fluid balance refers to the net fluid 
accumulation in the body.24  Simply, it is calculated by measuring all inputs and outputs over a 
certain period of time.24  Fluid overload is used to describe a fluid state in patients that have too 
much fluid accumulation.24  More specifically, fluid overload can be defined as greater than 10% 
fluid accumulation, which has been associated with worse patient outcomes.24  It can be 
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calculated by dividing the patient s fluid balance by the patient s baseline body weight, then 
multiplying it by 100%.17 
Generally, fluid resuscitation in patients with sepsis and septic shock should be divided 
into four phases: rescue, optimization, stabilization, de-escalation.7  In the rescue phase, initial 
fluid resuscitation is initiated to combat hypoperfusion.7  Next, during the optimization phase, 
the need for additional fluid boluses should be evaluated and administered to optimize cardiac 
output and tissue perfusion, while weighing the benefits and risks.7  During the stabilization 
phase, usually occurring 24 to 48 hours after the onset of septic shock, an effort should be made 
to achieve a neutral or slightly negative fluid balance in patients.7  Finally, the de-escalation 
phase is characterized by resolving organ dysfunction and shock, and aggressive fluid removal 
strategies should be used.7  Because the aim of this paper is on the initial resuscitation of patients 
with sepsis or septic shock, the focus will remain on the resuscitation phase.   
Post-fluid Administration Physiology 
 Currently, there are very limited randomized controlled trials focused on the 
physiological effects of fluid resuscitation in septic patients.25 In a review performed by 
Glassford et al., researchers looked at physiological effects immediately post-infusion of a fluid 
bolus at timeframes of 30, 60, and over 60 minutes.25  In six of the studies included in the 
review, the reported cardiac index increased after receiving a fluid bolus by a median of 800 
ml/min/m2 (range: 0 to 1,300 ml/min/m2), while the median heart rate decreased by two beats per 
minute (bpm) (range: 0 to 10 bpm reduction).25  The median increase in MAP was 7 mmHg 
(range: 1 to 15.2 mmHg), while the median increase in CVP was 3.2 mmHg (range: 2.3 to 
5.2mmHg).25  At 30 minutes post-administration, the cardiac index was increased by a median of 
300 ml/min/m2 (range: -400 to 600 ml/min/m2), the median heart rate was reduced by 2 bpm 
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(range: 11  reduction to 0.3 bpm increase), the median MAP was increased by 7.5 mmHg (range: 
3 to 11 mmHg), and the CVP was increased by 3 mmHg (range: 2 to 5.25 mmHg).25  Finally, at 
60 minutes post-administration, the cardiac index was increased by a median of 300 ml/min/m2 
(range: -300 to 400 ml/min/m2), the heart rate decreased by 1 bpm (range: 11 bpm reduction to 2 
bpm increase), the median change in MAP was a 3 mmHg increase (range: 2 to 7 mmHg), and 
the median CVP increase was 2 mmHg (range: 1 to 3 mmHg).25  While this review was 
important as it attempted to quantify physiologic changes after a fluid bolus in sepsis patients, 
the heterogeneity of studies was high, varying in fluid type (crystalloid versus colloid), definition 
of bolus volume, and other elements.25  However, the review was able to demonstrate that fluids 
can help raise the cardiac index, decrease heart rate, increase MAP, and increase CVP, though 
these changes are relatively transient.25  Other studies have demonstrated that during this first 
fluid bolus, cardiac output will increase in almost all cases.17  After the initial bolus, subsequent 
fluid administration may be harmful, since preload responsiveness is unlikely.17 
Approaches to Fluid Administration in Sepsis and Septic Shock 
Throughout the past couple decades, researchers have explored several different 
approaches to administering intravenous fluids to septic patients as well as how to quantify a 
patient s response.17,19  Large randomized controlled multicenter trials have established that there 
is no difference in patient outcome between colloid versus crystalloid solution administration to 
septic patients.3,19  Regardless, this led the SSC to recommend that crystalloid solution be used as 
the resuscitation fluid of choice.3  Furthermore, recent studies suggest that the use of a balanced 
crystalloid, such as lactated ringers or Plasma-Lyte, decreases the risk of renal injury, 
hyperchloremia, metabolic acidosis, and may lower mortality.7 
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Optimal therapeutic endpoints for fluid resuscitation remain unclear and are subjects of 
controversy.4-6  Although early goal-directed therapy (EGDT) is endorsed by the SSC and was 
initially shown to improve outcomes, it has since been questioned, and other methods for guiding 
fluid resuscitation have been proposed.17  Traditionally, the goal of resuscitation was to optimize 
CVP to 8 to 12 mmHg for non-ventilated patients or 12 to 15 mmHg for patients on a 
ventilator.26  More recently, the use of invasive monitoring to evaluate CVP and pulmonary 
capillary wedge pressure (PCWP) to guide fluid responsiveness in patients has been questioned, 
showing no improvement in outcomes and may even be dangerous, especially in severe septic 
shock.17,24  In one study, it was found that following an EGDT protocol led to fluid overload in 
67% of patients after 24 hours.13 
Researchers have advocated to move away from static measurements such as CVP, which 
is found to be accurate in only half of cases, to an approach using dynamic measurements.7  One 
example of a dynamic measurement approach is administering either a small fluid bolus or 
passively raising the patient s legs while simultaneously lowering the patient from a 
semirecumbent position to supine.7  Raising the patient s legs has been shown to act as a small 
fluid challenge,  shifting 200 to 300 milliliters of blood from the lower extremities into the 
central circulation.  Subsequent cardiac output is measured by a variety of means, including 
thermodilution, echocardiography, or pulse pressure variation.7  The measurement can then be 
used to determine volume responsiveness.  Quantitatively, volume responsiveness can be defined 
as an increase of stroke volume or cardiac output by 10% to 15% after a 200 to 500 milliliters 
fluid bolus.27 While one meta-analysis found a risk reduction in death of -2.9% in ICU patients 
resuscitated with a volume-responsiveness approach, only a subset of the sample patients were 
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septic.27  In fact, another study suggests that this volume-responsiveness approach  showed no 
difference in mortality compared to standard resuscitation strategies.27 
Another data point that can be used to guide fluid resuscitation is lactate levels.7  
Trending serum lactate values has been shown to decrease the high mortality rate associated with 
septic patients with levels > 4 mmol/L.7  In sepsis, lactate levels rise as a result of increased 
anaerobic respiration from hypoxic tissues, accelerated glycolysis due to the body s stress 
response, medications administered (such epinephrine or beta-2 agonists), or liver failure.7  
Intuitively, effective fluid resuscitation will result in down-trending lactate levels as tissue 
oxygenation is optimized.7   
Recently, a study published in 2020 investigated an alternative method to guide 
resuscitation involving the use of skin perfusion parameters, such as capillary refill time, distal 
skin temperatures, and skin mottling as a surrogate for visceral organ perfusion.28  The study 
concluded that capillary refill times better reflected organ perfusion compared to serum lactate 
levels.28  In addition, using skin perfusion parameters resulted in lower fluid volumes 
administered to patients and lower lactate levels at 48 and 72 hours.28  Although reported 
mortality was lower as well, this was not found to be statistically significant.28   
Liberal Versus Restrictive Approach to Fluid Administration 
Initial resuscitation of septic patients with intravenous fluids remains a mainstay of 
current treatment.29  Over the past two decades, two predominant strategies of fluid 
administration have emerged: a liberal fluid approach and a restrictive fluid approach.29  In the 
liberal fluid approach, larger volumes of crystalloid fluids are administered.  The volumes of 
fluid vary greatly but generally consist of 50 to75 ml/kg.29  In the restrictive approach, fluids are 
given in smaller amounts of ≤ 30 ml/kg of crystalloid.29  Due to the emergence of data 
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illustrating the prevalence and potential dangers of a positive fluid balance in septic patients, a 
new wave of studies seeking to shift the paradigm away from large volume resuscitation have 
occurred.29 
 As researchers continue to investigate different fluid treatment modalities in septic 
patients, approaches continue to be generally categorized into the two different groups: liberal 
fluid approach and restrictive fluid approach.29  Importantly, definitions vary widely from study 
to study regarding the definition of a liberal versus restrictive approach and at what point during 
resuscitation the patients are enrolled in the study.  This can potentially skew results if not 
closely examined.  For example, some studies referring to a restrictive approach may only enroll 
patients into the restrictive treatment group after they have already received the recommended 30 
ml/kg crystalloid fluid bolus.  In contrast, another study may enroll patients into the restrictive 
group from triage in the emergency department (ED) and begin the restrictive fluids approach 
immediately.  Due to this inconsistency, careful attention to the methods of studies is important. 
Generally speaking, a liberal fluid approach is most commonly utilized in the ED in the 
United States, consisting of an intravenous fluids (typically 50 to 75 ml/kg) over several hours to 
treat hypotension in septic patients.29  Resuscitation endpoints are based on SSC 
recommendations derived from EGDT.29  Vasopressors are administered to patients who are 
profoundly hypotensive or those who remain hypotensive despite fluid therapy.29  As mentioned 
previously, early studies initially supported the use of a liberal fluid approach when treating 
septic patients.29  However, more recent data has challenged this approach, citing questionable 
efficacy and dangers, such as fluid overload.5,30 
 In contrast, a restrictive fluid approach involves smaller volumes of fluid (typically ≤ 30 
ml/kg) and earlier introduction of vasopressors to reduce vasodilation and improve perfusion of 
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the patient s tissues.29  Data has shown that large fluid boluses only transiently increase 
intravascular volume and cardiac output, ultimately leading to downstream complications such as 
tissue edema and organ dysfunction.29  With this in mind, a fluid restrictive approach aims to 
minimize the harmful sequelae caused by large fluid boluses. 
Fluid Overload Complications 
Understanding the dangers of fluid overload in patients with sepsis is fundamental in 
making a clinical decision as to when to begin fluid administration, at what volume, and when to 
discontinue the infusion.  According to one study, fluid overload was observed in 67% of 
patients in the first 24 hours and in 48% of patients on day three using an EGDT approach.13  
This led to increased fluid-related medical interventions, such as thoracentesis, paracentesis, 
diuretic administration, and ultrafiltration for fluid removal.13  Lastly, the study showed an 
increased mortality with the use of an EDGT approach.13  Due to the high incidence of fluid 
overload and the associated increase in mortality, it is important to understand the complications 
that can occur in order to recognize and minimize their effects. 
Fluid overload in septic patients can lead to worsening multisystem dysfunction and 
adverse outcomes.5  This further dysfunction can be found in the cardiovascular, pulmonary, 
central nervous system, renal system, gastrointestinal system, and hepatic system.5,31  
Physiologically, large volume resuscitation may potentiate damage and shedding of the 
endothelial glycocalyx, especially when it is infused rapidly. 5  Moreover, one study found that 
the volume of resuscitation fluids was independently associated with the degree of glycocalyx 
degradation and, ultimately, in-hospital mortality.5 These complications lead to longer ICU stays, 
increased days on the mechanical ventilator, increased medical interventions, and higher 
mortality.5 
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Interestingly, it has been shown that an increase in fluid can actually cause more cardiac 
dysfunction and the need for an increased amount of vasopressors in patients with sepsis.5  The 
Fluid Expansion As Supportive Therapy (FEAST) trial, during which pediatric patients were 
randomized to receive 40 ml/kg of saline, albumin, or no fluid resuscitation, was stopped early 
after a 40% increase in mortality that occurred in the fluid treatment group of the study.5  It was 
later determined the cause of increased death in the fluid treatment group was not due to fluid 
overload itself but because of delayed cardiovascular collapse and refractory shock.5  In 2017, 
the results of an RCT in Zambia showed that despite greater amounts of fluids received, patients 
required greater usage of vasopressors and ultimately experienced higher mortality than the usual 
treatment group (58% versus 36%, respectively).32  In a hyperdynamic sheep model, it was found 
that a large fluid bolus prior to administration of a vasopressor resulted in increased cardiac 
output and MAP as expected; however, a simultaneous drop in systemic vascular resistance was 
noted.5  Animals also showed signs of resistance to vasopressors along with increased evidence 
of myocardial and glycocalyx damage reflected by elevated troponin and hyaluronan levels.5 
Given the harm that can occur from potentially causing the septic patient to become fluid 
overloaded, fluid restrictive approaches arose.  During the Refresh Fluid Resuscitation in 
Suspected Sepsis Associated Hypotension (REFRESH) trial in 2018, patients were randomly 
assigned to either a usual care group or a fluid restrictive group.33  The fluid restrictive protocol 
for septic patients with hypotension involved early introduction of a vasopressor paired with a 
small 250 milliliter fluid bolus.33  At the conclusion of this trial, there was a 30% reduction in the 
total fluid volume received in the first 24 hours and significant positive change in outcome.33  In 
addition, the fluid restriction did not result in longer vasopressor use.33  Therefore, this may be a 
feasible alternative to the standard 30 ml/kg fluid bolus seen in the SSC guidelines, which would 
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decrease the potential for harm secondary to fluid overload.  Similar results were seen in the 
Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS) trial, in which no increase 
in mortality, organ failure, or adverse events were noted.34 
Early Norepinephrine Administration 
To further investigate the optimal treatment for patients with sepsis and septic shock, 
studies have been conducted to analyze the effect of introducing early vasopressors during the 
initial resuscitation period of treatment.  The administration of an early vasopressor, specifically 
norepinephrine as a first line vasopressor, aims to restore the vascular tone in septic shock to 
help maintain a MAP ≥ 65 mmHg to ensure organ perfusion.35 Studies have shown that after the 
very early phase of sepsis, only half of patients are fluid-responsive.35 The 2016 SSC guidelines 
recommend that vasopressors be used if a patient is rapidly deteriorating or when initial fluid 
bolus administration fails to maintain a MAP ≥ 65 mmHg.12  While some advocate for the early 
administration of norepinephrine, there is limited data in the literature investigating how the 
timing of vasopressor administration affects mortality and other patient outcomes.36,38  The goals 
of early norepinephrine administration are to prevent prolonged severe hypotension, increase 
cardiac output through increased preload, improve microcirculation and tissue oxygenation, 
prevent fluid overload, and improve outcomes.36   
 Studies have demonstrated that both the degree and duration of hypotension are crucial in 
maximizing patient outcomes in septic shock.36 In addition, fluid administration alone may not 
be sufficient to correct severe hypotension.36 Adding a potent vasoconstrictor, such as 
norepinephrine, may shorten the time to correction, therefore shorting the duration of 
hypotension.36  The shorter time to correction of severe hypotension can be attributed to 
norepinephrine s effects on the vasculature.  At low doses of norepinephrine (less than 2 
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mcg/min), beta-1 agonist effects may be more pronounced, while at higher doses (higher than 3 
mcg/min), alpha-1 agonist effects predominate.36  The stimulation of these receptors have been 
shown to increase cardiac output when administered early, leading to increased blood pressure, 
organ perfusion, and ultimately improved outcomes.36  In a study that looked at patients who 
have been resuscitated in less than three hours by standard treatment whose MAP remained 
below 65 mmHg, echocardiographic variables were obtained to address the effects of 
norepinephrine administration.36  Following administration of norepinephrine, an increase in 
right and left ventricular systolic function was observed in addition to increased cardiac output. 36  
Interestingly, experimental data has shown a time-dependent effect on beta-1 stimulation, during 
which an early potentiated beta-1 response was seen followed by a downregulation phase, 
suggesting that the greatest benefit from increased contractility is seen in the early phase of 
septic shock.36 
Early norepinephrine administration may even be beneficial in hypotensive patients with 
a MAP slightly greater than 65 mmHg but who have a low diastolic arterial pressure (DAP).38 
Although a low DAP can be due to other physiological causes such as bradycardia or arterial 
stiffness, it is most likely due to the decreased arterial tone in septic patients.38  Therefore, 
norepinephrine can be administered to augment vessel tone and increase cardiac output through 
increased preload.36  This may be especially beneficial in septic patients with a history of 
coronary artery disease, as a higher DAP can increase coronary perfusion and help prevent 
ischemia.38 
The Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER) trial, a single 
center, randomized, double-blinded, placebo-controlled clinical trial, investigated the effects of 
early norepinephrine administration on septic shock control.39   This was defined as a MAP ≥ 65 
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mmHg, urine flow ≥ 0.5 ml/kg/h for 2 consecutive hours, or decreased serum lactate ≥ 10% from 
baseline.39  At the conclusion of the trial, it was found that patients in the early norepinephrine 
group had a higher frequency of shock control compared to the control group (76.1% versus 
48.4%).39   It is important to note that in this study, patients received a standard 30 ml/kg normal 
saline bolus prior to randomization.39   
Previously, concerns for impaired microcirculation secondary to norepinephrine 
administration have been brought up; however, recent data suggests that microcirculation may 
actually improve.36, 40  In a study by Georger et al., researchers found that the tissue oxygen 
saturation (StO2) recovery curve slope improved after increasing MAP with the administration of 
norepinephrine in septic shock patients.36  Even when the MAP ≥ 65 mmHg, clinical studies 
showed increasing the MAP to ≥ 85 mmHg did not impair microcirculation after norepinephrine 
administration.36 
As mentioned previously, a positive fluid balance is associated with an increased 
mortality rate in patients with septic shock.  This is due to tissue edema, damage to the 
endothelial glycocalyx, increased venous pressure, and hemodilution.  Early administration of 
norepinephrine has been shown to decrease the fluid requirements of patients in septic shock, 
minimizing the risks of fluid overload.40   
The optimal timing of early administration of norepinephrine remains unclear.40  The 
widespread acceptance of initially administering 30 ml/kg of crystalloid prior to consideration of 
a vasopressor is reflected in many studies that randomize patients only after they have received a 
fluid bolus.40  However, recent studies have questioned the clinical benefit of fluid bolus 
administration in patients with septic shock.40  In fact, recent experimental data suggests that 
fluid resuscitation preceding the start of vasopressors is associated with higher lactic acid levels 
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and paradoxical increase in vasopressor dose and duration requirements compared to the 
immediate start of a vasopressor without previous fluid administration.40 
In one retrospective cohort study intended to determine the effects of vasopressors 
administered before or after 6 hours from admission, researchers found that the 30-day mortality  
was higher in patients who received vasopressors after 6 hours (51.1% versus 25%).38  In 
addition, although the data did not show any difference in vasopressor dose at the 24-hour mark, 
patients who received earlier vasopressors had more vasopressor-free hours by the 72-hour mark 
of care (34.5 hour versus 13.1 hour).38  Lastly, early vasopressor administration shortened the 
time it took to reach a target MAP of ≥ 65 mmHg.38 
A randomized controlled trial involving patients in septic shock found that patients who 
received a norepinephrine infusion between 20 to 30 minutes (early group) had quicker 
restoration of blood pressure, better lactate clearance, and lower mortality rates compared to 
those who received the infusion 120 to 180 minutes (late group) after admission to the 
emergency department (28.1% versus 54.4%, respectively).36  The early group received 
crystalloid fluids concurrently with the norepinephrine infusion, while the late group received a 
standard 30 ml/kg targeted fluid resuscitation.36 
A prospective study addressing the effects of early vasopressor administration showed 
similar results.40  In this study, patients were categorized based on whether or not they received a 
vasopressor prior or within one hour of their first fluid bolus of crystalloid.40  In the group that 
received early vasopressors, there was a smaller volume of resuscitation fluid received in the first 
8 hours (1100 versus 2600 milliliters) with no significant increase in acute renal failure.40  Due to 
this, there was also a lower net fluid balance at 8 and 24 hours.40  Finally, there was a significant 
reduction in mortality compared to the delayed vasopressor group.40 
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IV. Methods 
Sepsis and Septic Shock Background Information 
To gain an understanding of the current treatment options for sepsis and septic shock, a 
search was performed in UpToDate using the phrase Treatment of Sepsis in Adult Patients.   
This led to the article named Evaluation and Management of Suspected Sepsis and Septic Shock 
in Adults.   Additionally, a search utilizing PubMed was performed with the following search 
phrases, selecting articles published in the last five years: Surviving Sepsis Campaign;  SEP-
1;  WHO Sepsis Global Health;  SEPSIS-3;  Epidemiology AND Sepsis;  and Cost of 
Sepsis.   
Fluid Administration in Sepsis and Septic Shock 
To obtain information regarding the administration of fluids in sepsis, a PubMed search 
was performed using the following search terms: Fluid Management AND Sepsis;  Fluid 
Administration AND Sepsis;  Fluid Resuscitation AND Sepsis;  Volume Resuscitation AND 
Sepsis;  Volume Administration AND Sepsis;  Fluid Overload AND Sepsis;  Harms of Fluid 
Overload AND sepsis;  Treatment of Sepsis;  Surviving Sepsis Campaign AND Outcomes;  
Restrictive AND Fluid AND Sepsis;  Initial resuscitation AND sepsis;  Fluid Approach to 
Sepsis;  Early Norepinephrine AND Sepsis;  and Early Vasopressor* AND Sepsis.   The 
search was again performed using the same terms listed above but sepsis  was replaced with 
septic shock.   To acquire a variety of articles, reviews, systematic reviews, randomized 
controlled trials, clinical trials, and meta-analyses were included.  The search date range for all 
PubMed searches was modified to articles published from 2010 to 2020, with an emphasis in 
selecting articles published in the past five years. 
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V. Discussion 
 Sepsis and septic shock continues to carry an in-hospital mortality rate of 25 to 50%, 
posing a challenge to patients and healthcare providers alike.2,3  This complex condition also 
carries a high cost burden on the healthcare system, costing roughly $20.3 billion annually.3  In 
an effort to decrease the mortality of sepsis by 25%, the European Society of Intensive Care 
Medicine (ESICM), International Sepsis Forum (ISF), and Society of Critical Care Medicine 
(SCCM) developed the Surviving Sepsis Campaign (SSC) guidelines, releasing them in 2004.9  
As part of their 2018 update of the 2016 guidelines, the Hour-1 Bundle included a 
recommendation to immediately start a rapid infusion of 30 ml/kg crystalloid to be completed 
within three hours.3  This came as a strong recommendation with low quality evidence.10  The 
evidence for these guidelines came from a limited number of interventional and observational 
studies, and recent studies have challenged the data.3,5 
 Studies suggest that blindly giving the fluid bolus, as recommended by the SSC 
guidelines, commonly results in a positive fluid balance, leading to complications, greater need 
for medical interventions, longer ICU stays, and greater mortality.13  Some argue this is partly 
due to the vagueness of the recommendations themselves.5,10  For example, it is unclear whether 
the 30 ml/kg should be based off of the patient s actual weight, estimated weight, or ideal body 
weight.10  Hospital ICUs may not have beds that can weigh patients, and the ones that do may 
not provide an accurate weight.  In addition, the patients who are obese may end up receiving 
harmful amounts of fluid if their actual weight is utilized in the calculation.5  It has also been 
shown that staff in the ICU are notoriously unreliable when estimating patients  weights.5  This 
poses an obvious risk, as over- or under-estimating a patient s weight can quickly cause incorrect 
dosing of the fluid bolus.  This is particularly important in patients with comorbidities such as 
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congestive heart failure.10  Blindly administering a 30 ml/kg fluid bolus can be especially 
dangerous in states, such as New York, where practitioners are mandated per the CMS SEP-1 
quality control measures to administer 30 ml/kg to septic patients as part of their care, or they 
face a possible malpractice lawsuit.5  In fact, some organizations, such as the Infectious Diseases 
Society of America (IDSA), do not endorse the SSC guidelines, as they are not in favor of an all-
or-none type of approach to sepsis and septic shock.10  
 Instead of a rigid treatment approach, some studies advocate for a more individualized 
approach to fluid resuscitation in patients.  The SSC guidelines are based on EGDT, which is 
supported by researchers such as Rivers et al.19  However, this approach has been scrutinized, as 
well as studies suggesting that there are safer alternatives that can be used as resuscitative 
endpoints.7,27  For example, some studies recommend that dynamic measures be used, such as 
cardiac output, to better gauge fluid responsiveness.7  Using dynamic measures in conjunction 
with small fluid challenges of 250 to 500 milliliters of crystalloid creates a more tailored 
approach and can decrease the risk of fluid overload in patients.  Studies have shown that only 
half of sepsis patients are fluid responsive at baseline.35  Multiple boluses of fluid have also been 
shown to be ineffective at improving hemodynamic parameters.35  In addition, the physiologic 
effects of a fluid bolus have been shown to be only transient effects on parameters, such as 
cardiac output and MAP.25  Additional dynamic measures have been studied that may hold 
promise as a surrogate for organ perfusion, such as skin perfusion.28 
 Researchers continue to investigate different fluid approaches, including utilizing a fluid 
restrictive versus a liberal fluid approach.  Despite the importance of this research, there are 
issues regarding these two approaches.  First, there is a lack of uniformity amongst definitions 
across the medical literature, specifically what is considered restrictive versus liberal.  While 
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some restrictive approaches involve minimizing fluids from the moment a patient is triaged, 
other studies begin enrollment after the patient has already received a 30 ml/kg fluid bolus.  This 
may lead to some confusion and heterogeneity in review studies. However, studies have shown 
that a restrictive approach is both feasible and safe for patients, minimizing positive fluid 
balances, minimizing fluid overload complications, and ultimately improving outcomes.5,32,33 
 Another variable that must be considered during fluid resuscitation of septic patients is 
the addition of vasopressors.  Recent data has alleviated concerns about early administration of 
vasopressors, in particular norepinephrine, proving that early administration of vasopressors 
either after a small fluid challenge or concurrently with a fluid bolus can improve 
outcomes.37,38,40 Additionally, early vasopressor administration actually decreases the amount of 
fluid required to maintain a MAP ≥ 65 mmHg, results in smaller doses of vasopressors required 
to maintain an adequate MAP, and can result in serum lactate clearance.37,38,40  This ultimately 
shortens the time a patient experiences hypotension, leading to less organ dysfunction.37  Due to 
a limited number of trials available in the literature, more studies are needed to evaluate the 
optimal timing of vasopressor administration to maximize benefit and decrease mortality.    
VI. Conclusion 
 Given the associated high mortality and high cost in the healthcare system, sepsis and 
septic shock remain one of the top global health priorities.1  Due to the complexity of the 
pathophysiology of sepsis and septic shock, there are many different components to treatment, 
making studying each component as independent variables difficult.  Although guidelines have 
been published outlining recommended treatments, more research needs to be conducted.4  The 
SSC guidelines are certainly a step in the right direction to improve the care provided to sepsis 
and septic shock patients.  However, as more research is completed and the knowledge base 
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grows, these guidelines need to evolve to reflect current data and optimize patient outcomes.  In 
addition, a more tailored approach to fluid resuscitation may provide benefit by reducing fluid 
overload and improving patient outcomes.  
It is clear that clinicians must be cautious when administering fluid boluses to septic 
patients, as it may lead to further organ dysfunction, additional medical interventions, and even 
higher mortality compared to a restrictive fluid approach.  By administering small fluid 
challenges of 250 to 500 milliliters crystalloid and using dynamic measures, such as cardiac 
output, to monitor the patient s response, it can minimize a positive fluid balance and help 
minimize fluid overload complications.  Adding vasopressors early in the resuscitation can also 
decrease the need for fluids to maintain adequate perfusion and minimize the time necessary to 
correct hypotension in septic shock patients.  It is still unknown, however, what the optimal 
volume of fluid administered should be or at what time during resuscitation vasopressors should 
be initiated to maximize patient outcomes, so further research is needed. 
 In order to continue improving the medical knowledge surrounding fluid administered to 
patients with sepsis and septic shock, a consensus on the definitions of restrictive and liberal 
fluid approaches needs to be established.  As mentioned previously, different studies enroll 
patients into the trials at different points in their care.  Specifically, studies vary on whether 
patients are enrolled before or after an initial fluid bolus has already been administered.  To truly 
compare these approaches, studies need to use specific definitions and consistent timing of fluid 
bolus initiation to adequately evaluate the different approaches and increase homogeneity 
amongst studies.  Another layer of complexity in study design is ensuring that these trials are 
conducted in a manner that can evaluate each approach as an independent variable rather than as 
part of different treatment arms seen in many studies on this topic.  Ideally, these studies can be 
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designed as randomized controlled trials with two treatment approaches. This may be difficult as 
there are many different treatment options being studied for the care of septic patients, and fluid 
administration is a small piece of the overall puzzle.  In addition, future trials should evaluate 
and establish the ideal approach to be used to accurately measure the response to the fluid bolus.  
These parameters need to be both practical and accurate.  Lastly, more research focused on the 
use of early vasopressors should be conducted compared to fluid bolus administration, as early 
data has shown promise in improving outcomes and decreasing complications associated with 
fluid overload. 
 Currently, the Crystalloid Liberal Or Vasopressor Early Resuscitation in Sepsis 
(CLOVERS) trial is being conducted comparing these strategies.29  This randomized multicenter 
trial aims to determine the outcomes of a restrictive versus liberal fluid approach in the first 24 
hours among adult patients in the United States.29  The primary outcome of this study is focused 
on in-hospital mortality to day 90, with secondary outcomes of ventilator-free days, and organ-
failure free days until day 28.29  Although this is one example of a current trial being conducted, 
similar studies will help to provide valuable insight, which will continue to improve the care 
delivered to sepsis and septic shock patients. 
 The care of sepsis and septic shock patients can be equally as complicated as the 
pathophysiology involved in the condition itself.  Thus far, great strides have been made in the 
medical community attempting to lower the high mortality rate, but future research is required to 
continue this positive trend.  As more data becomes available, it is important for clinicians caring 
for sepsis and septic shock patients to keep up to date on medical literature to ensure the best 
care is provided to these patients.  Although fluid administration is only one facet in the overall 
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care of sepsis and septic shock patients, its potential to affect downstream sequelae make it an 
essential component of resuscitation and improving morbidity and mortality. 
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